{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:28:49Z","timestamp":1774571329625,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","license":[{"start":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T00:00:00Z","timestamp":1715904000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,17]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Thrombotic thrombocytopenic purpura (TTP) is a syndrome characterized by widespread blood vessel clotting and bleeding. It can affect individuals of any age but is more commonly observed in females, particularly during pregnancy. Pregnancy combined with TTP is a critical and rapidly progressing condition that is often misdiagnosed as an obstetric disorder like severe preeclampsia or HELLP syndrome. To deepen the understanding of TTP during pregnancy with the help of a clinical case.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 20-year-old patient, is pregnancy 1 birth 0, 32 weeks dated by her last menstrual period, presented chest tightness, and shortness of breath after physical activity for 3 days.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>TTP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>At present, there are no preventive measures. Timely diagnosis and treatment are useful. Plasma exchange and treat to the patient hinder autoantibodies, such as gamma globulin, methylprednisolone, rituximab, and cyclosporine were effective.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient exhibited stable vital signs, normal examination results, and experienced no complications. We continued to monitor her progress after she was discharged.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons subsections:<\/jats:title>\n            <jats:p>The acute onset of TTP is often associated with pregnancy, as it is a triggering factor. Timely identification, accurate diagnosis, and a comprehensive treatment approach involving plasma exchange, immunosuppressants, and the termination of pregnancy can lead to remission and a favorable outlook for the majority of patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000038112","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T05:50:20Z","timestamp":1716011420000},"page":"e38112","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Case report of thrombotic thrombocytopenic purpura during pregnancy with a review of the relevant research"],"prefix":"10.1097","volume":"103","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-na","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Xi\u2019an People\u2019s Hospital, Xi\u2019an, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-xia","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9315-9828","authenticated-orcid":false,"given":"Gu-Yuan","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250503","first-page":"187","article-title":"Thrombotic thrombocytopenic purpura.","volume":"111","author":"Atrash","year":"2015","journal-title":"J Ark Med Soc"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/j.amjmed.2017.04.022","article-title":"An unusual presentation of thrombotic thrombocytopenic purpura.","volume":"130","author":"Zhou","year":"2017","journal-title":"Am J Med"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1751143717715969","article-title":"Diagnostic dilemma: severe thrombotic microangiopathy in pregnancy.","volume":"18","author":"Birkhoelzer","year":"2017","journal-title":"J Intensive Care Soc"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10067-013-2312-5","article-title":"Clinical features and prognostic factors of thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus: a literature review of 105 cases from 1999 to 2011.","volume":"33","author":"Jiang","year":"2014","journal-title":"Clin Rheumatol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"e2020028","DOI":"10.4084\/mjhid.2020.028","article-title":"Covid-19 and children with immune thrombocytopenia: emerging issues.","volume":"12","author":"Lassandro","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.transci.2015.11.005","article-title":"Pregnancy associated thrombotic thrombocytopenic purpura: practical issues for patient management.","volume":"53","author":"Savignano","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s13023-014-0193-6","article-title":"Pregnancy complications in acquired thrombotic thrombocytopenic purpura: a case-control study.","volume":"9","author":"Ferrari","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/joacc.JOACC_10_19","article-title":"Thrombocytopenic purpura during pregnancy and its overlap with the HELLP syndrome, a clinical dilemma: a case report and review of the literature.","volume":"9","author":"Basta","year":"2019","journal-title":"J Obstet Anaesth Crit Care"},{"key":"R10-20250503","first-page":"206","article-title":"A retrospective study of pregnancy thrombotic thrombocytopenic purpura-five cases report.","volume":"18","author":"Pan","year":"2018","journal-title":"J Trop Med"},{"key":"R11-20250503","first-page":"983","article-title":"Chinese expert consensus on diagnosis and treatment of thrombotic thrombocytopenic purpura (2012 Edition).","volume":"33","year":"2012","journal-title":"Chin J Hematol"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1182\/blood-2016-10-709857","article-title":"Thrombotic thrombocytopenic purpura.","volume":"129","author":"Joly","year":"2017","journal-title":"Blood"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1172\/JCI41062","article-title":"N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice.","volume":"121","author":"Chen","year":"2011","journal-title":"J Clin Invest"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJMc1213206","article-title":"ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.","volume":"368","author":"Shortt","year":"2013","journal-title":"N Engl J Med"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/j.1538-7836.2011.04224.x","article-title":"Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies.","volume":"9","author":"Plaimauer","year":"2011","journal-title":"J Thromb Haemost"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1182\/blood-2011-09-380535","article-title":"A new mouse model mimicking thrombotic thrombocytopenic purpura: correction of symptoms by recombinant human ADAMTS13.","volume":"119","author":"Schiviz","year":"2012","journal-title":"Blood"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1505533","article-title":"Caplacizumab for acquired thrombotic thrombocytopenic purpura.","volume":"374","author":"Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa1806311","article-title":"Caplacizumab treatment for acquired thrombotic thrombocytopenic purpura.","volume":"380","author":"Scully","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:06:19Z","timestamp":1746317179000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,17]]},"references-count":17,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038112","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,17]]}}}